http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-111841-C2

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4741
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-436
filingDate 2012-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UA-111841-C2
titleOfInvention BENZOTHIAZOL COMPOUNDS AND THEIR PHARMACEUTICAL APPLICATION
abstract The invention relates to compounds of formula I or their salts, as well as pharmaceutical compositions containing a compound of formula I, a method of obtaining compounds of formula I, intermediate compounds that are acceptable for the preparation of compounds of formula I, and therapeutic methods for treating HIV virus proliferation, AIDS treatment or delay Aids or ARC symptoms in a mammal using compounds of formula I.
priorityDate 2011-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409451045

Total number of triples: 35.